Automation startup Qventus launched a new AI assistant designed to alleviate healthcare staff’s administrative burden by completing mundane tasks for them. The assistant was built in collaboration with health systems, including Northwestern Medicine, Ardent Health and Allina Health.
Health systems across the country are launching enterprise-wide deployments of AI-powered clinical documentation tools. Hospital leaders agree that this technology reduces physician burnout, as well as allows physicians to have more meaningful and productive interactions with patients.
In an increasingly urbanized world, the allure of countryside living is growing stronger, especially when it comes to health and well-being.
A third health system has started using Cytovale’s early sepsis detection test. Froedtert & the Medical College of Wisconsin Health Network announced its plans to deploy the diagnostic test this week.
The eBook Femtech Revolution: How Entrepreneurs Are Championing Women’s Health Equity highlights femtech to help track menstruation, how femtech can support access to care, data privacy concerns, and more.
Clarium, a startup on a mission to transform hospital supply chain operations, closed a $10.5 million financing round this week. The round was led by General Catalyst and included three health system venture capital arms — those of Kaiser Permanente, Yale New Haven Health and Texas Medical Center.
The theme of the Pitch Perfect contest at INVEST Digital Health in Dallas is pediatric mental health. Six companies will compete in the event at Pegasus Park on September 18. Register today!
These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.
After several quarters with little to no exit activity in the medtech space, several startups made exits in the second quarter of 2024, according to a new report.
Cresilon snagged its second FDA clearance for human use. The FDA granted 510(k) clearance to Traumagel, the startup’s gel that can stop bleeding in just seconds, for temporary external use to control moderate to severe bleeding.
Caresyntax closed a $180 million Series C extension round, bringing its Series C fundraising total to $310 million. The company sells AI-based precision surgery technology that unifies operating room data on a single platform.
Check out news from Alpha Sophia, MD Ally, Guardoc Health, and more.
The path forward is clear: employers must evaluate their health plan the same way they do their Saturday shopping excursion.
Current trends are driven by various strategic and financial considerations from both established pharmaceutical companies and development-stage biotech firms. Understanding the valuation and accounting implications of these transactions are crucial for stakeholders to navigate the complex landscape effectively.
Dan Easton, Unorthodox Ventures Principal, is one of the judges for the INVEST Pitch Perfect startup contest, which will focus on pediatric mental health. In response to emailed questions, Easton shared the firm's approach to healthcare startups.
Create Health Ventures announced the close of its inaugural $21 million fund, which is focused on technology for payers. This is because payers are “the lynchpin” for the types of change that the fund wants to see, such as better care access and improved population health outcomes, Managing Partner Amit Aysola said.
This latest eBook highlights the content of our conferences -- INVEST in Chicago and INVEST Digital Health in Dallas. It spotlights talks such as Small business Education and Entrepreneurial Development funding, investor perspectives on AI, women’s health, health tech implementation, medtech trends, cybersecurity, and drug development innovation. They also spotlight winners from our startup pitch contest Pitch Perfect.
Apple Tree Partners’ latest startup is Red Queen Therapeutics, developer of stapled peptide drugs that block viral fusion. Its lead program is on track for Phase 2 testing in immunocompromised Covid-19 patients; a preclinical pan-influenza program is in development under a BARDA contract.